Pricing Log in Create free account

Clovis Oncology, Inc. (CLVSQ) vs SeaStar Medical Holding Corporation (ICU)

Clovis Oncology, Inc. and SeaStar Medical Holding Corporation are both Biotechnology companies. Clovis Oncology, Inc. and SeaStar Medical Holding Corporation are of similar size ($14.2M and $13.5M). SeaStar Medical Holding Corporation grew revenue faster over the last twelve months: 123.6% against −14.8%. Clovis Oncology, Inc. has the higher net margin (−189.4% vs −795.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Clovis Oncology, Inc. leads on 9 and SeaStar Medical Holding Corporation on 6.

Valuation

Metric CLVSQ ICU Biotechnology median
P/E n/m n/m 8.50
P/S 0.10 6.99 9.71
P/B n/m 2.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.08 4.42 9.21
Earnings yield (2,033.33%) (133.45%) (33.15%)
Free cash flow yield (1,412.40%) (114.43%) (25.50%)

Profitability

Metric CLVSQ ICU Biotechnology median
Gross margin 72.21% 92.64% 65.16%
Operating margin (155.38%) (816.75%) 0.00%
Net margin (189.37%) (795.50%) 0.00%
Free cash flow margin (132.19%) (799.36%) 0.00%
Return on equity 78.31% (356.87%) (56.36%)
Return on assets (58.94%) (160.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLVSQ ICU Biotechnology median
Revenue growth (TTM) (14.78%) 123.63% 6.02%
EPS growth (last fiscal year) 47.72% 91.16% 30.26%
Revenue growth, 5-year CAGR 352.98% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVSQ ICU Biotechnology median
Debt to equity (1.05) 0.00 0.00
Current ratio 0.14 1.89 4.72
Net debt to EBITDA (2.16) 0.99 0.96

Dividend

Metric CLVSQ ICU Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLVSQ ICU Biotechnology median
Market cap 14.23m 13.48m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack